protein-based bioassay
Bio-Techne, Carterra Partner on COVID-19 Variant Analysis
The firms are developing a high-throughput, scalable assay for the screening and characterization of SARS-CoV-2 spike and receptor-binding domain variants.
Bio-Techne, 908 Devices Partner on Protein Characterization
The firms said that pairing Bio-Techne's Maurice icIEF protein separation instrument with 908 Devices' ZipChip platform enables a workflow that increases scientists' drug development efficiency.
The spatial molecular imager will be NanoString's next play in a growing market that it says is worth more than $12 billion, including diagnostic applications.
Founded last year, the company plans to develop mass spec-based tests to protein isoforms using a workflow that eliminates both LC and protein digestion.
Amarantus Reacquires Neurology Diagnostic Assets from Avant
Amarantus has reacquired LymPro Test, MSPrecise, and NuroPro and said that it plans to assign the assets to a new subsidiary.